 |
|
|
| |
Viral Responses in African Americans, Latinos, and Caucasians in the US Phase 2 Study (PROVE1) of Telaprevir with Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve, Genotype 1-Infected Patients with Hepatitis C
|
| |
| |
AASLD 2008 SF
Reported by Jules Levin
Andrew J Muir,1 Eric J Lawitz,2 John G McHutchison,1 Stuart C Gordon,3 Ira M Jacobson,4 Bambang S Adiwijaya,5 Leif Bengtsson,5 Lindsay McNair,5 Maribel Rodriguez-Torres6
1Duke Clinical Research Institute, Durham, NC, USA; 2Alamo Medical Research, San Antonio, TX, USA; 3Henry Ford Hospital, Detroit, MI, USA; 4Weill Medical College of Cornell University, New York, NY, USA; 5Vertex Pharmaceuticals Incorporated, Boston, MA, USA; 6Fundacion de Investigacion de Diego, Ponce School of Medicine, San Juan, Puerto Rico
|
| |
|
|
|
|
|
